Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis
Loading...
Date
Authors
Ntais, C.
Polycarpou, A.
Ioannidis, J. P.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Cancer Epidemiol Biomarkers Prev
Book name
Book series
Book edition
Alternative title / Subtitle
Description
A T-to-C polymorphism in the 5' promoter region of the CYP17 gene that encodes the cytochrome P450c17alpha has been implicated as a risk factor for prostate cancer, but individual studies have been inconclusive or controversial. Therefore we performed a meta-analysis of 10 studies (12 comparisons) with CYP17 genotyping on 2404 patients with prostate cancer and 2755 controls. Overall, the random effects odds ratio (OR) for the A2 (C) versus A1 (T) allele was 1.08 [95% confidence interval (CI), 0.95-1.22], with some between-study heterogeneity (P = 0.04). There was no suggestion of an overall effect either in recessive or dominant modeling of A2 effects, and the comparison of A2/A2 versus A1/A1 also showed no differential susceptibility to prostate cancer (OR, 1.15; 95% CI, 0.91-1.46). No effect of A2 was seen in subjects of European descent (7 comparisons, OR, 1.04; 95% CI, 0.92-1.18, no significant between-study heterogeneity) or Asian descent (2 comparisons, OR, 1.06; 95% CI, 0.66-1.71; P = 0.02 for heterogeneity), whereas A2 increased susceptibility to prostate cancer in subjects of African descent (3 comparisons, OR, 1.56; 95% CI, 1.07-2.28; no between-study heterogeneity). Smaller studies unilaterally showed more prominent genetic effects for A2 than larger studies (P = 0.038). The meta-analysis suggests that the CYP17 polymorphism is unlikely to increase considerably the risk of sporadic prostate cancer on a wide population basis, especially in subjects of European descent. Previously reported associations may reflect publication bias, although it is also possible that the polymorphism may be important in subjects of African descent.
Description
Keywords
Africa/epidemiology, Age Factors, Alleles, Asia/epidemiology, Case-Control Studies, Europe/epidemiology, Genetic Markers/genetics, Genetic Predisposition to Disease/ethnology/genetics, Humans, Male, Polymorphism, Genetic/*genetics, Prostatic Neoplasms/diagnosis/epidemiology/*genetics, Risk Factors, Statistics as Topic, Steroid 17-alpha-Hydroxylase/*genetics, Tumor Markers, Biological/genetics
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/12582021
http://cebp.aacrjournals.org/content/12/2/120.full.pdf
http://cebp.aacrjournals.org/content/12/2/120.full.pdf
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής